Showing results (191-200 of 259) with videos related to
Sort By:
Pageof 26
Journal of Medicinal Chemistry|January 3, 2026
Discovery and Characterization of a First-In-Class HCK/BTK PROTAC DFCI-002-06 for the Treatment of MYD88 Mutated B Cell MalignanciesJohn M Hatcher, Shirong Liu, Amanda Kofides, et al.Seminars in Hematology|May 25, 2025
Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom's MacroglobulinemiaShayna Sarosiek, Anne-Marie L Becking, Andrew Branagan, et al.American Journal of Hematology|July 24, 2010
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström MacroglobulinemiaIrene M Ghobrial, Wanling Xie, Swaminathan Padmanabhan, et al.Cancer Research|December 17, 2005
Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implicationsYu-Tzu Tai, Xian-Feng Li, Laurence Catley, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2015
Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström MacroglobulinemiaIsere Kuiatse, Veerabhadran Baladandayuthapani, Heather Y Lin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2018
Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191Haiwen Ni, Fazal Shirazi, Veerabhadran Baladandayuthapani, et al.British Journal of Haematology|December 22, 2015
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective studyJorge J Castillo, Shirley D'Sa, Michael P Lunn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180Steven P Treon, Leukothea Ioakimidis, Jacob D Soumerai, et al.Leukemia & Lymphoma|May 3, 2008
Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemiaXavier Leleu, Anne-Sophie Moreau, Edie Weller, et al.Pageof 26